Search
Your search found total of 613 results
Dr. Alena Savonenko obtained her Ph.D. in behavioral neuroscience at the Lomonosov Moscow State University and completed a post-doctoral fellowship at the Nencki Institute of Experimental Biology, Warsaw, Poland. Later, she continued her post-doctoral education at the Johns Hopkins University.…
She came to CSR from the National Human Genome Research Institute at NIH, where she was a staff scientist for the last ten years. Prior this, she worked at the National Cancer Institute. Dr. Topol is a graduate of the Moscow State University with a bachelor degree in physiology, and she has a Ph.D…
Dr. Sudha Veeraraghavan received Ph.D. in biophysics and biochemistry from the University of Texas Health Science Center in San Antonio, where she conducted research in the area of protein folding. As a postdoctoral fellow she trained in structural biology at Tufts University School of Medicine and…
Dr. Maria Cardenas-Corona joined CSR following her retirement as a research professor emeritus of molecular genetics and microbiology at Duke University School of Medicine. During her academic career, her studies focused on the elucidation of the mechanism of action of the anti-cancer,…
Dr. Bryan Crenshaw earned his Ph.D. in biology from the University of California, San Diego, where he studied the role of transcription factors in the development of the pituitary and brain. After postdoctoral training at UCSD, he joined the faculty of the University of Chicago in the Departments…
Dr. Tang-Toth received her Ph.D. degree from Johns Hopkins University and did her postdoctoral training as an IRTA fellow within the Cell Biology and Metabolism Program at the NIH National Institute of Child Health and Human Development. Prior to joining CSR, Dr. Tang-Toth was an associate…
Dr. Yi Liu earned his Ph.D. in molecular microbiology and immunology and received his postdoctoral training in developmental genetics from the University of Southern California. Prior to joining CSR, he was an associate professor of research and the principal investigator and co-investigator of NIH…
Does the NIH policy on rigor and transparency apply to all types of NIH grants?
Where in grant applications should applicants address the four focus areas of the NIH policy on rigor and transparency?
I’m confused about the term “scientific premise or rigor” and how it is different from “…
Dr. Brian Chadwick received his Ph.D. in human genetics from Imperial Cancer Research Fund and University College London, he then trained in molecular neurogenetics at Harvard Medical School and Massachusetts General Hospital before continuing his training in epigenetics and human X chromosome…
Dr. Low received her early education in Australia and Canada. Pursuing an interest in studying how animal behavior arises from brain physiology, she received her Ph.D. in neuroscience from Northwestern University. Her thesis work studying circadian rhythmic behavior in Clock mutant chimeric mice…
Dr. Roger Bannister began his Ph.D. studies in biology at the University of Iowa and completed his thesis at Utah State University. He received his post-doctoral training in the Department of Physiology and Biophysics at the University of Colorado and was then appointed to a tenure-track faculty…
Dr. Dolores Arjona earned her Ph.D. in molecular biology and biochemistry at the Universidad Autonoma of Madrid in Spain. She subsequently completed her postdoctoral training at Virginia Commonwealth University and the Neuro-Oncology Branch at NCI. Her main research efforts were focused on…
Dr. Marci Scidmore received her Ph.D. in molecular biology from Princeton University. After her postdoctoral training at the Rocky Mountain Laboratories at the National Institute of Allergy and Infectious Diseases (NIAID) studying host-pathogen interactions of Chlamydia, she continued her NIH-…
Dr. Methode Bacanamwo received his Master of Science degree from Clemson University and his doctoral degree in biochemistry from the University of Illinois at Urbana-Champaign. Following post-doctoral trainings at the Universities of Arkansas and Missouri, he joined the faculty at the Morehouse…
Dr. Christopher Payne received his Ph.D. in cell and developmental biology at the Oregon Health and Science University, where he studied the mechanisms regulating cytoskeletal and membrane dynamics during mammalian fertilization. Following postdoctoral training at the Fred Hutchinson Cancer…
Dr. Andersen received her Ph.D. in behavioral neuroscience from the State University of New York at Binghamton. She furthered her training at Harvard Medical School, becoming a faculty member in the Department of Psychiatry and directing her laboratory for nearly 30 years. Dr. Andersen studied how…
Dr. Barry Margulies received B.S. at MIT in Applied Biological Sciences, with research in controlled release technology. He earned his Ph.D. at the Johns Hopkins University School of Medicine in biochemistry, cellular, and molecular biology, where he studied the G protein-coupled receptors encoded…
Dr. Guillermo Bermejo earned his Ph.D. from Carnegie Mellon University in the field of biophysics/structural biology, largely focusing on the computational analysis of data from nuclear magnetic resonance (NMR) spectroscopy to facilitate the protein structure elucidation process. He then conducted…
Dr. Victor Panchenko holds a Ph.D. in biological sciences from the National Academy of Sciences, Ukraine. Prior to joining CSR Dr. Panchenko was a Tech Transfer Project Manager at Amgen, Inc and worked on their first anticancer program small molecule KRAS inhibitor. Before that he worked as a…
Ms. Carla Ward is an Ethics Program Specialist located in the Office of the Director. She, along with other Ethics Specialists, are responsible for being the first line of contact for employees. Ms. Ward assists CSR’s Deputy Ethics Counselor with handling the day-to-day functioning of…
